OTHER INFORMATION.
−Removed: the quarter ended March 31, 2024, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement”
+Added: the quarter ended June 30, 2024, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement”
or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
−Removed: Form of Securities Purchase Agreement (incorporated by reference to exhibit 10.1 to current report on Form 8-K, furnished to the SEC on February 15, 2024)
−Removed: Form of Convertible Promissory Note (incorporated by reference to exhibit 10.2 to current report on Form 8-K, furnished to the SEC on February 15, 2024)
−Removed: Form of Registration Rights Agreement (incorporated by reference to exhibit 10.3 to current report on Form 8-K, furnished to the SEC on February 15, 2024)
−Removed: First Amendment to Securities Purchase Agreement (incorporated by reference to exhibit 10.4 to current report on Form 8-K, furnished to the SEC on February 15, 2024)
−Removed: Third Amendment to Securities Purchase Agreement, dated March 22, 2024, between the Company and Flagstaff International, LLC (incorporated by reference to exhibit 10.1 to current report on Form 8-K, furnished to the SEC on March 28, 2024)
−Removed: Form of Convertible Promissory Note issued to Flagstaff International, LLC (incorporated by reference to exhibit 10.2 to current report on Form 8-K, furnished to the SEC on March 28, 2024)
−Removed: Certification
−Removed: pursuant to 18 U.S.C.
+Added: Form of Securities Purchase Agreement (incorporated by reference to exhibit 10.1 to current report on Form 8-K, furnished to the SEC on May 28, 2024)
+Added: Form of Convertible Promissory Note (incorporated by reference to exhibit 10.2 to current report on Form 8-K, furnished to the SEC on May 28, 2024)
+Added: Form of Registration Rights Agreement (incorporated by reference to exhibit 10.3 to current report on Form 8-K, furnished to the SEC on May 28, 2024)
+Added: Form of Unrestricted Stock Award Agreement by and between Neuraxis, Inc.
+Added: and Grantees dated on July 1, 2024 (incorporated by reference to exhibit 10.1 to current report on Form 8-K, furnished to the SEC on July 5, 2024)
+Added: Certification pursuant to 18 U.S.C.
Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer
−Removed: Certification
−Removed: pursuant to 18 U.S.C.
+Added: Certification pursuant to 18 U.S.C.
Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer
−Removed: Certification
−Removed: pursuant to 18 U.S.C.
+Added: Certification pursuant to 18 U.S.C.
Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer
−Removed: Certification
−Removed: pursuant to 18 U.S.C.
+Added: Certification pursuant to 18 U.S.C.
Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer
10 unchanged sentences
the undersigned, thereunto duly authorized.
+Added: August 9, 2024
Brian Carrico
1 unchanged sentence
Executive Officer)
+Added: August 9, 2024
Timothy Henrichs
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.